Vacuum Assisted Closure in Neck Abscess
Vacuum Assisted Closure in Deep Neck Abscess
1 other identifier
interventional
28
1 country
1
Brief Summary
The presence of deep abscess in the neck is potentially severe, it can also lead to death in short term. The surgical treatment is indicated when there is commitment of the airway, critical condition, septicemia, complications, descendent infections, diabetes mellitus with no improving during the first 48 hours of parenteral antibiotic treatment and subsequent healing of the wounds until it heals by second intention. In this study investigators propose the use of vacuum Assisted Closure (VAC) that has been used satisfactorily to reduce edema, promote granulation, and ameliorate the tissue to afterwards reconstruct the defect, increase vascularity and diminish the bacterial load.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2010
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 27, 2014
CompletedFirst Posted
Study publicly available on registry
April 3, 2014
CompletedApril 22, 2014
April 1, 2014
9 months
March 27, 2014
April 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Granulation tissue percentage
the percentage of granulation tissue will be evaluated by a software called image Image J
every 3 days up to 3 months
Secondary Outcomes (2)
complications
every 3 days up to 3 months
microorganisms
every 7 days up to 3 months
Other Outcomes (1)
mortality
Up to 6 months
Study Arms (2)
VAC Therapy
ACTIVE COMPARATORactive comparator: 14 patients within the first three days the VAC therapy was placed , proceeding as follows : organize the material , bandage removal , cleaning of the wound with irrigation solution , cut the sponge and placement on the wound , use of polyvinyl alcohol and / or silver foam, insertion of the tube seal and connection to the containing recipient.
Traditional Therapy
PLACEBO COMPARATOR14 patients: after surgical drainage, a culture was taken, photographs every three days (during hospital stay ) and secretion culture; daily cleaning stipulated by the service was perform. The control of the patients were made until wound closure (presence of epithelialization tissue) .
Interventions
within the first three days the VAC therapy was placed , proceeding as follows : Wound cleaning was performed with irrigating solution and replacement of the sponges every 72 hours according to evolution, photographs were taken to assess the percentage of viable tissue and granulation. A Sample to culture was taken prior to placement of VAC therapy , during the use of it and at the time of removal of the system. When the wound presents clinical signs of improvement (elimination of purulent discharge and granulation tissue ) VAC therapy was withdrawn , and follow by delayed primary closure.
after surgical drainage, a culture was taken, photographs every three days (during hospital stay ) and secretion culture; daily cleaning stipulated by the service was perform. The control of the patients were made until wound closure (presence of epithelialization tissue) .
Eligibility Criteria
You may qualify if:
- Male or female patients of 18 years or older
- Diagnosis of Deep Neck Abscess users of the Mexican Institute of Social Security
- Incision from the anterior edge of the SCM muscle to unilateral or bilateral paratracheal line
- Spread of infection to a space larger than 7 cm
- Patients with systemic diseases
You may not qualify if:
- Patients with extensive necrosis of tissue that does not allow the suture of the wound
- Patients who for some reason do not conclude the study
- Patients with complications that require taking off the VAC Therapy
- Patients who miss their follow
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Medical Center, Mexican Institute of Social Security
Guadalajara, Jalisco, 44340, Mexico
Study Officials
- STUDY DIRECTOR
Clotilde Fuentes-Orozco, PhD
Instituto Mexicano del Seguro Social
- PRINCIPAL INVESTIGATOR
Luis H Govea-Camacho, PhD
Instituto Mexicano del Seguro Social
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
March 27, 2014
First Posted
April 3, 2014
Study Start
September 1, 2010
Primary Completion
June 1, 2011
Study Completion
September 1, 2013
Last Updated
April 22, 2014
Record last verified: 2014-04